Trio Petroleum Corp (NYSE American: TPET) ("Trio" or the "Company"), an oil and gas company, today is pleased to announce that its wholly owned Canadian subsidiary, Trio Petroleum Canada, Corp. (the ...
The positive regulatory development follows Gyre’s May 2025 announcement of successful Phase 3 trial results, where Hydronidone met its primary endpoint with 52.85% of treated patients achieving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback